Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
Identifieur interne : 000361 ( Main/Exploration ); précédent : 000360; suivant : 000362Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
Auteurs : Raymond L. Benza [États-Unis] ; Dave P. Miller [États-Unis] ; Aimee J. Foreman [États-Unis] ; Adaani E. Frost [États-Unis] ; David B. Badesch [États-Unis] ; Wade W. Benton [États-Unis] ; Michael D. Mcgoon [États-Unis]Source :
- The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [ 1557-3117 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Enregistrements, Facteurs temps, Femelle, Humains, Hypertension pulmonaire (), Hypertension pulmonaire (mortalité), Hypertension pulmonaire (physiopathologie), Hémodynamique (physiologie), Mâle, Prise en charge de la maladie, Pronostic, Taux de survie (tendances), Épreuve d'effort, États-Unis d'Amérique (épidémiologie), Études de suivi, Études prospectives, Évaluation des risques ().
- MESH :
- mortalité : Hypertension pulmonaire.
- physiologie : Hémodynamique.
- physiopathologie : Hypertension pulmonaire.
- tendances : Taux de survie.
- épidémiologie : États-Unis d'Amérique.
- Adulte d'âge moyen, Enregistrements, Facteurs temps, Femelle, Humains, Hypertension pulmonaire, Mâle, Prise en charge de la maladie, Pronostic, Épreuve d'effort, Études de suivi, Études prospectives, Évaluation des risques.
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- Disease Management, Exercise Test, Female, Follow-Up Studies, Hemodynamics (physiology), Humans, Hypertension, Pulmonary (mortality), Hypertension, Pulmonary (physiopathology), Hypertension, Pulmonary (therapy), Male, Middle Aged, Prognosis, Prospective Studies, Registries, Risk Assessment (methods), Survival Rate (trends), Time Factors, United States (epidemiology).
- MESH :
- geographic , epidemiology : United States.
- methods : Risk Assessment.
- mortality : Hypertension, Pulmonary.
- physiology : Hemodynamics.
- physiopathology : Hypertension, Pulmonary.
- therapy : Hypertension, Pulmonary.
- trends : Survival Rate.
- Disease Management, Exercise Test, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Registries, Time Factors.
Abstract
Data from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) were used previously to develop a risk score calculator to predict 1-year survival. We evaluated prognostic implications of changes in the risk score and individual risk-score parameters over 12 months.
DOI: 10.1016/j.healun.2014.09.016
PubMed: 25447572
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000520
- to stream PubMed, to step Curation: 000520
- to stream PubMed, to step Checkpoint: 000520
- to stream Ncbi, to step Merge: 004104
- to stream Ncbi, to step Curation: 004104
- to stream Ncbi, to step Checkpoint: 004104
- to stream Main, to step Merge: 000361
- to stream Main, to step Curation: 000361
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.</title><author><name sortKey="Benza, Raymond L" sort="Benza, Raymond L" uniqKey="Benza R" first="Raymond L" last="Benza">Raymond L. Benza</name><affiliation wicri:level="2"><nlm:affiliation>Allegheny General Hospital, Division of Cardiovascular Diseases, Pittsburgh, Pennsylvania. Electronic address: rbenza@wpahs.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Allegheny General Hospital, Division of Cardiovascular Diseases, Pittsburgh</wicri:cityArea></affiliation></author><author><name sortKey="Miller, Dave P" sort="Miller, Dave P" uniqKey="Miller D" first="Dave P" last="Miller">Dave P. Miller</name><affiliation wicri:level="2"><nlm:affiliation>ICON Clinical Research, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ICON Clinical Research, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Foreman, Aimee J" sort="Foreman, Aimee J" uniqKey="Foreman A" first="Aimee J" last="Foreman">Aimee J. Foreman</name><affiliation wicri:level="2"><nlm:affiliation>ICON Clinical Research, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ICON Clinical Research, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Frost, Adaani E" sort="Frost, Adaani E" uniqKey="Frost A" first="Adaani E" last="Frost">Adaani E. Frost</name><affiliation wicri:level="2"><nlm:affiliation>Baylor College of Medicine, Division of Cardiovascular Diseases, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Baylor College of Medicine, Division of Cardiovascular Diseases, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Badesch, David B" sort="Badesch, David B" uniqKey="Badesch D" first="David B" last="Badesch">David B. Badesch</name><affiliation wicri:level="2"><nlm:affiliation>University of Colorado Denver, Division of Pulmonary Sciences and Critical Medicine, Aurora, Colorado.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Colorado</region></placeName><wicri:cityArea>University of Colorado Denver, Division of Pulmonary Sciences and Critical Medicine, Aurora</wicri:cityArea></affiliation></author><author><name sortKey="Benton, Wade W" sort="Benton, Wade W" uniqKey="Benton W" first="Wade W" last="Benton">Wade W. Benton</name><affiliation wicri:level="2"><nlm:affiliation>Actelion Pharmaceuticals US, Inc, South San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Actelion Pharmaceuticals US, Inc, South San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Mcgoon, Michael D" sort="Mcgoon, Michael D" uniqKey="Mcgoon M" first="Michael D" last="Mcgoon">Michael D. Mcgoon</name><affiliation wicri:level="2"><nlm:affiliation>Mayo Clinic, Division of Cardiovascular Diseases, Rochester, Minnesota.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Minnesota</region></placeName><wicri:cityArea>Mayo Clinic, Division of Cardiovascular Diseases, Rochester</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25447572</idno><idno type="pmid">25447572</idno><idno type="doi">10.1016/j.healun.2014.09.016</idno><idno type="wicri:Area/PubMed/Corpus">000520</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000520</idno><idno type="wicri:Area/PubMed/Curation">000520</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000520</idno><idno type="wicri:Area/PubMed/Checkpoint">000520</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000520</idno><idno type="wicri:Area/Ncbi/Merge">004104</idno><idno type="wicri:Area/Ncbi/Curation">004104</idno><idno type="wicri:Area/Ncbi/Checkpoint">004104</idno><idno type="wicri:Area/Main/Merge">000361</idno><idno type="wicri:Area/Main/Curation">000361</idno><idno type="wicri:Area/Main/Exploration">000361</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.</title><author><name sortKey="Benza, Raymond L" sort="Benza, Raymond L" uniqKey="Benza R" first="Raymond L" last="Benza">Raymond L. Benza</name><affiliation wicri:level="2"><nlm:affiliation>Allegheny General Hospital, Division of Cardiovascular Diseases, Pittsburgh, Pennsylvania. Electronic address: rbenza@wpahs.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Allegheny General Hospital, Division of Cardiovascular Diseases, Pittsburgh</wicri:cityArea></affiliation></author><author><name sortKey="Miller, Dave P" sort="Miller, Dave P" uniqKey="Miller D" first="Dave P" last="Miller">Dave P. Miller</name><affiliation wicri:level="2"><nlm:affiliation>ICON Clinical Research, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ICON Clinical Research, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Foreman, Aimee J" sort="Foreman, Aimee J" uniqKey="Foreman A" first="Aimee J" last="Foreman">Aimee J. Foreman</name><affiliation wicri:level="2"><nlm:affiliation>ICON Clinical Research, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ICON Clinical Research, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Frost, Adaani E" sort="Frost, Adaani E" uniqKey="Frost A" first="Adaani E" last="Frost">Adaani E. Frost</name><affiliation wicri:level="2"><nlm:affiliation>Baylor College of Medicine, Division of Cardiovascular Diseases, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Baylor College of Medicine, Division of Cardiovascular Diseases, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Badesch, David B" sort="Badesch, David B" uniqKey="Badesch D" first="David B" last="Badesch">David B. Badesch</name><affiliation wicri:level="2"><nlm:affiliation>University of Colorado Denver, Division of Pulmonary Sciences and Critical Medicine, Aurora, Colorado.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Colorado</region></placeName><wicri:cityArea>University of Colorado Denver, Division of Pulmonary Sciences and Critical Medicine, Aurora</wicri:cityArea></affiliation></author><author><name sortKey="Benton, Wade W" sort="Benton, Wade W" uniqKey="Benton W" first="Wade W" last="Benton">Wade W. Benton</name><affiliation wicri:level="2"><nlm:affiliation>Actelion Pharmaceuticals US, Inc, South San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Actelion Pharmaceuticals US, Inc, South San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Mcgoon, Michael D" sort="Mcgoon, Michael D" uniqKey="Mcgoon M" first="Michael D" last="Mcgoon">Michael D. Mcgoon</name><affiliation wicri:level="2"><nlm:affiliation>Mayo Clinic, Division of Cardiovascular Diseases, Rochester, Minnesota.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Minnesota</region></placeName><wicri:cityArea>Mayo Clinic, Division of Cardiovascular Diseases, Rochester</wicri:cityArea></affiliation></author></analytic><series><title level="j">The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation</title><idno type="eISSN">1557-3117</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Disease Management</term><term>Exercise Test</term><term>Female</term><term>Follow-Up Studies</term><term>Hemodynamics (physiology)</term><term>Humans</term><term>Hypertension, Pulmonary (mortality)</term><term>Hypertension, Pulmonary (physiopathology)</term><term>Hypertension, Pulmonary (therapy)</term><term>Male</term><term>Middle Aged</term><term>Prognosis</term><term>Prospective Studies</term><term>Registries</term><term>Risk Assessment (methods)</term><term>Survival Rate (trends)</term><term>Time Factors</term><term>United States (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Enregistrements</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Hypertension pulmonaire ()</term><term>Hypertension pulmonaire (mortalité)</term><term>Hypertension pulmonaire (physiopathologie)</term><term>Hémodynamique (physiologie)</term><term>Mâle</term><term>Prise en charge de la maladie</term><term>Pronostic</term><term>Taux de survie (tendances)</term><term>Épreuve d'effort</term><term>États-Unis d'Amérique (épidémiologie)</term><term>Études de suivi</term><term>Études prospectives</term><term>Évaluation des risques ()</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Risk Assessment</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Hypertension, Pulmonary</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Hypertension pulmonaire</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Hémodynamique</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Hemodynamics</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Hypertension pulmonaire</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Hypertension, Pulmonary</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Taux de survie</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hypertension, Pulmonary</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Survival Rate</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Management</term><term>Exercise Test</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prognosis</term><term>Prospective Studies</term><term>Registries</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Enregistrements</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Hypertension pulmonaire</term><term>Mâle</term><term>Prise en charge de la maladie</term><term>Pronostic</term><term>Épreuve d'effort</term><term>Études de suivi</term><term>Études prospectives</term><term>Évaluation des risques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Data from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) were used previously to develop a risk score calculator to predict 1-year survival. We evaluated prognostic implications of changes in the risk score and individual risk-score parameters over 12 months.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li><li>Colorado</li><li>Minnesota</li><li>Pennsylvanie</li><li>Texas</li></region></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Benza, Raymond L" sort="Benza, Raymond L" uniqKey="Benza R" first="Raymond L" last="Benza">Raymond L. Benza</name></region><name sortKey="Badesch, David B" sort="Badesch, David B" uniqKey="Badesch D" first="David B" last="Badesch">David B. Badesch</name><name sortKey="Benton, Wade W" sort="Benton, Wade W" uniqKey="Benton W" first="Wade W" last="Benton">Wade W. Benton</name><name sortKey="Foreman, Aimee J" sort="Foreman, Aimee J" uniqKey="Foreman A" first="Aimee J" last="Foreman">Aimee J. Foreman</name><name sortKey="Frost, Adaani E" sort="Frost, Adaani E" uniqKey="Frost A" first="Adaani E" last="Frost">Adaani E. Frost</name><name sortKey="Mcgoon, Michael D" sort="Mcgoon, Michael D" uniqKey="Mcgoon M" first="Michael D" last="Mcgoon">Michael D. Mcgoon</name><name sortKey="Miller, Dave P" sort="Miller, Dave P" uniqKey="Miller D" first="Dave P" last="Miller">Dave P. Miller</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000361 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000361 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25447572
|texte= Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25447572" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |